← Browse by Condition
Medical Condition
unresectable hepatocellular carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1, Phase 2
NCT05103904 Phase 2
Recruiting
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
Enrollment
19 pts
Location
United States
Sponsor
Emory University
NCT07482059 Phase 1, Phase 2
Recruiting
A Multicenter Clinical Study of Combined Therapy for Unresectable Hepatocellular Carcinoma
Enrollment
33 pts
Location
China
Sponsor
West China Hospital